What AWAK Technologies does

AWAK Technologies is a Singapore-based medical device company founded in 2007 that develops wearable and portable peritoneal dialysis systems intended for at-home treatment of chronic kidney disease (CKD). The company's core product is a miniaturized wearable peritoneal dialysis platform built around proprietary regenerative dialysis sorbent technology, designed to replicate the function of a normal kidney and free patients from the immobility and clinic-based scheduling imposed by conventional hemodialysis machines.

The platform is targeted at two complementary customer groups: chronic kidney disease patients who require regular dialysis and want treatment delivered outside clinical settings, and home healthcare providers building out home-based renal care programs. AWAK is currently pre-commercial; it has no paying customers, no disclosed pricing, and generates no revenue. The company is advancing through a structured regulatory pathway, running a pre-pivotal trial in Singapore and preparing a pivotal trial in the United States to support future FDA clearance and North American market entry.

AWAK's go-to-market model is sales-led and hardware-based: once regulatory approvals are secured, the company plans to distribute its wearable dialysis devices directly to healthcare providers and patients in Singapore and the United States. Capital to fund this clinical and product roadmap has come from venture investors, including a Series B of over US$20 million in September 2023 (one of the largest MedTech raises in Southeast Asia that year) led by Lion X Ventures and Vickers Venture Partners, following a roughly US$40 million round in 2019 led by Vickers Venture Partners with participation from Enterprise Singapore and Seeds Capital.

Name

AWAK Technologies

Legal name

AWAK Technologies

Website

https://awak.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

AWAK Technologies is a Singapore-based medical device company developing a wearable peritoneal dialysis system with proprietary regenerative sorbent technology for at-home treatment of chronic kidney disease patients, currently pre-commercial and advancing through clinical trials in Singapore and the United States.

Ownership category

akta.pro rank

Product category

Wearable Dialysis Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB)

akta.pro secondary industries

Home Dialysis Support & Training Providers (HLAFAEAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)

Keywords

• Wearable dialysis devices
• Peritoneal dialysis systems
• Home dialysis technology
• Kidney failure treatment
• Portable medical devices

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Wearable Dialysis Devices: The company develops and plans to commercialize wearable peritoneal dialysis systems for at-home use by chronic kidney disease patients. Revenue will be generated through device sales once regulatory approvals are obtained.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

AWAK Technologies develops a wearable peritoneal dialysis system designed for at-home treatment of chronic kidney disease patients. The device miniaturizes traditional dialysis machines into a portable, regenerative form factor, enabling continuous dialysis outside clinical settings. The product is currently in clinical development, with a pre-pivotal trial underway in Singapore and a pivotal trial planned in the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Wearable Peritoneal Dialysis System A wearable peritoneal dialysis system designed for at-home care of chronic kidney disease patients. The device enables portable dialysis treatment, miniaturizing traditional dialysis machines for increased convenience and improved quality of life. Currently undergoing pre-pivotal clinical trials in Singapore with a pivotal trial planned in the United States.

Quantifiable outcome

• Improved patient quality of life through portable, at-home dialysis treatment

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Outset Medical: Outset Medical develops the Tablo, a portable/home hemodialysis system aimed at simplifying in-home and clinic-based dialysis. Like AWAK, it focuses on miniaturization and ease of use to enable home-based renal replacement therapy, making it the closest direct analog in the wearable/portable dialysis category.
• Baxter International: Baxter is the global leader in peritoneal dialysis systems (HomeChoice, Amia APD) and a dominant incumbent in the PD market AWAK is targeting. It competes head-to-head with AWAK in home PD and represents both the primary competitive threat and a potential strategic acquirer.
• Quanta Dialysis Technologies: Quanta develops the SC+ portable hemodialysis system for home and clinic use, with an emphasis on simplicity and portability. It is a directly comparable device-focused peer pursuing the same home-dialysis shift as AWAK.

Broad incumbents

• Fresenius Medical Care: Fresenius Medical Care is the world's largest dialysis products and services company, operating thousands of dialysis centers and producing a broad portfolio of dialysis machines, PD systems, and consumables. It competes with AWAK across virtually every dialysis modality and is the most formidable incumbent in the category.
• DaVita: DaVita is one of the largest US dialysis service providers with significant investment in home dialysis programs (including PD). While primarily a services operator rather than a device maker, it is a major customer/partner channel for home-dialysis device companies like AWAK.

Emerging players

• Debiotech: Swiss medtech Debiotech has worked on miniaturized/wearable artificial kidney and dialysis concepts. It is an emerging peer in the wearable dialysis innovation space, sharing AWAK's focus on miniaturization but at an earlier commercialization stage.
• Diality: Diality is developing a portable hemodialysis platform targeting both clinic and home settings. As a smaller, venture-backed device competitor, it competes with AWAK for capital and clinical positioning in the home dialysis category.

Others

• US Renal Care: US Renal Care is a mid-sized US dialysis services provider with growing home dialysis offerings. It is relevant as a potential channel/customer for AWAK's wearable PD system rather than a direct device competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AWAK Technologies